RLAY
Relay Therapeutics Inc Earnings Dividend
$12.93
Earnings Summary
Revenue | $7Mn |
Net Profits | $-54.89Mn |
Net Profit Margins | -784.14% |
Relay Therapeutics Inc’s revenue jumped +Inf% since last year same period to $7Mn in the Q4 2025. On a quarterly growth basis, Relay Therapeutics Inc has generated +Inf% jump in its revenue since last 3-months.
Relay Therapeutics Inc’s net profit jumped 27.78% since last year same period to $-54.89Mn in the Q4 2025. On a quarterly growth basis, Relay Therapeutics Inc has generated 25.97% jump in its net profits since last 3-months.
Relay Therapeutics Inc’s net profit margin jumped NaN% since last year same period to -784.14% in the Q4 2025. On a quarterly growth basis, Relay Therapeutics Inc has generated NaN% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | -0.39 |
EPS Estimate Current Year | -0.39 |
Relay Therapeutics Inc’s earning per share (EPS) estimates for the current quarter stand at -0.39 - a 5.05% jump from last quarter’s estimates.
Relay Therapeutics Inc’s earning per share (EPS) estimates for the current year stand at -0.39.
Key Ratios
Earning Per Share (EPS) | 0 |
Relay Therapeutics Inc’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q1 2026. This indicates that the Relay Therapeutics Inc has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2026-04-30 | -0.39 | 0 | 100% |
